Derek Hicks insider trades
Open-market stock purchases and sales by Derek Hicks, EVP, Chief Business Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Jan 3, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NTLA Intellia Therapeutics, Inc: 3 sales, last Jan 3, 2025